<p>加拿大不列颠哥伦比亚省温哥华，2026 年 1 月 22 日（GLOBE NEWSWIRE）——Cannabix Technologies Inc.（CSE: BLO）（OTCID: BLOZF）（法兰克福: 8CT）（以下简称 “公司” 或 “Cannabix”）是一家大麻和酒精呼气测试设备的开发商，欣然宣布其大麻呼气测试（“MBT”）将出现在 2026 年 AlcoPro Inc.产品目录的封面上（见图 1）。AlcoPro Inc.（“AlcoPro”）总部位于田纳西州诺克斯维尔，是美国领先的专业药物和酒精检测仪器、工具和用品的供应商，自 1982 年以来为客户提供服务。2026 年 AlcoPro 产品目录将分发给超过 85,000 家美国及国际企业，包括执法机构和矫正部门。</p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1600" height="2100" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg"/></p>
<p>图 1. Cannabix Technologies Inc.的大麻呼气测试出现在 2026 年 AlcoPro Inc.产品目录的封面上</p>
<p>Cannabix 与 AlcoPro 一直密切合作，主要在美国市场进行 MBT 的预发布营销活动。</p>
<p>大麻呼气测试（MBT）系统结合了 Cannabix 的专有呼气采集单元和呼气卡匣技术，以捕获和保存非侵入性的呼气样本，供黄金标准的 LC-MS 分析。Cannabix 与 Omega Laboratories Inc.的战略合作伙伴关系——一家在法医药物检测领域拥有超过 25 年经验的全球领导者——为其提供了世界级的专业知识，得到了多个联邦和国际认证的支持，并在药物检测方面拥有数十年的创新经验。</p>
<p>AlcoPro 的业务发展总监 Brian Terry 表示：“我们对与 Cannabix Technologies 日益增长的关系以及 MBT 即将向我们的客户提供感到兴奋。我们正在超越传统的测试工具，转向能够提供当今工作场所所需准确性的先进技术。随着安全挑战的变化，保持领先地位，提供能够主动降低风险的解决方案对于保护员工至关重要。”</p>
<p><strong>关于 AlcoPro, Inc.</strong> 自 1982 年以来，AlcoPro 一直是雇主、医疗专业人员、执法机构和药物滥用专家信赖的药物和酒精检测解决方案的领导者。AlcoPro 以市场领先的呼气测酒仪等可靠仪器而闻名，还提供创新的在线培训，配备互动工具以增强知识保留。凭借全面的产品目录、便捷的在线订购和专业支持，AlcoPro 使工作场所检测变得简单、准确和专业。了解更多信息，请访问 www.AlcoPro.com。</p>
<p><strong>关于 Cannabix Technologies Inc.</strong> Cannabix Technologies Inc.是一家为执法机构、工作场所和实验室开发大麻和酒精呼气检测技术的公司。Cannabix 正在开发 delta-9 THC 和酒精筛查设备。Delta-9 THC 是大麻中的主要精神活性成分。对 delta-9 THC 进行呼气检测将使雇主和执法机构能够识别近期的大麻使用。Cannabix 是其_呼气 Logix 系列呼气酒精检测设备_的开发者，适用于雇主和其他多种场合。</p>
<p>我们寻求安全港。</p>
<p><em>代表董事会</em></p>
<p>“Rav Mlait”</p>
<p>首席执行官</p>
<p>Cannabix Technologies Inc.</p>
<p>如需更多信息，请联系公司，邮箱为 <strong>info@cannabixtechnologies.com</strong></p>
<p><strong><em>关于前瞻性声明的警示说明</em></strong></p>
<p>本新闻稿包含某些符合适用证券法下 “前瞻性声明” 定义的内容。前瞻性声明通常以 “预期”、“计划”、“继续”、“期望”、“项目”、“打算”、“相信”、“估计”、“可能”、“将”、“潜在”、“提议”、“定位” 等词语或某些事件或条件 “可能” 或 “将” 发生的声明为特征。本新闻稿中的前瞻性声明包括但不限于与以下内容相关的声明：实现本新闻稿中描述的任何或所有目标和目的；商业或原型产品的最终开发；公司技术的成功试验或试点；公司产品的商业化；与现有和新合作伙伴的额外协议的谈判和潜在签署；以及未来融资的完成。有许多风险和不确定性可能导致实际结果以及公司的计划和目标与前瞻性信息中表达的内容存在重大差异。可能导致实际结果与前瞻性信息中表达的内容存在重大差异的重要因素包括（但不限于）：不利的市场条件；关于保护专有技术的风险；公司完成未来融资的能力；公司开发和营销未来产品的能力；关于政府监管、管理和维持增长的风险、不利宣传的影响、诉讼、竞争；合作伙伴可能无法完成所有或任何战略合作协议中设想的里程碑；CSE 可能不批准证券的发行；公司开发的呼气分析仪技术是否会为公司带来任何好处没有保证；没有保证任何提议的新产品会被建造、在测试或临床试验中成功；没有保证公司会与任何合作伙伴建立合作关系以推进其任何企业计划或技术；没有保证公司许可或拥有的任何 “专利申请” 或 “临时专利” 技术会获得监管机构的专利状态；公司目前并未销售呼气分析仪，也没有保证公司将来会销售；以及其他超出公司控制的因素。实际结果和未来事件可能与预期的信息存在重大差异。这些及所有后续的书面和口头前瞻性信息均基于管理层在作出声明时的估计和意见，并完全受到本通知的明确限定。除法律要求外，公司不打算更新这些前瞻性声明。</p>
<p>CSE 未对本发布的充分性或准确性进行审查，也不承担任何责任。</p>
<p>与本公告相关的照片可在 https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398 获取。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png"/></p>

CBIH

CBSTF

<p>Cannabix Technologies Inc. 宣布其大麻呼吸测试（MBT）将出现在 AlcoPro 2026 产品目录的封面上。AlcoPro 是一家领先的药物和酒精检测仪器供应商，将向超过 85,000 家企业分发该目录。MBT 结合了 Cannabix 的呼吸采集单元和呼吸 cartridge 技术，以实现准确的呼吸样本分析。与 Omega Laboratories 的合作增强了 Cannabix 在药物检测方面的专业知识。AlcoPro 的业务发展总监对这一合作以及 MBT 提高工作场所安全的潜力表示兴奋</p>

<p>VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing devices, is pleased to announce that its Marijuana Breath Test (“MBT”) will be featured on the cover of the 2026 AlcoPro Inc. product catalogue (see Figure 1). AlcoPro Inc. (“AlcoPro”), based in Knoxville, TN, is a leading U.S. supplier of professional drug and alcohol testing instruments, kits, and supplies, serving customers since 1982. The 2026 AlcoPro product catalogue will be distributed to more than 85,000 businesses across the United States and internationally including law enforcement and the corrections segment.</p>
<div class="lb-trans"><p>加拿大不列颠哥伦比亚省温哥华，2026 年 1 月 22 日（GLOBE NEWSWIRE）——Cannabix Technologies Inc.（CSE: BLO）（OTCID: BLOZF）（法兰克福: 8CT）（以下简称 “公司” 或 “Cannabix”）是一家大麻和酒精呼气测试设备的开发商，欣然宣布其大麻呼气测试（“MBT”）将出现在 2026 年 AlcoPro Inc.产品目录的封面上（见图 1）。AlcoPro Inc.（“AlcoPro”）总部位于田纳西州诺克斯维尔，是美国领先的专业药物和酒精检测仪器、工具和用品的供应商，自 1982 年以来为客户提供服务。2026 年 AlcoPro 产品目录将分发给超过 85,000 家美国及国际企业，包括执法机构和矫正部门。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg" alt="" original-src="https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg"/></p>
<p>Figure 1. Cannabix Technologies Inc. Marijuana Breath Test featured on cover of 2026 AlcoPro, Inc. product catalog</p>
<div class="lb-trans"><p>图 1. Cannabix Technologies Inc.的大麻呼气测试出现在 2026 年 AlcoPro Inc.产品目录的封面上</p>
</div><p>Cannabix and AlcoPro have been working closely together on pre-launch marketing activities for the MBT primarily in the U.S. market.</p>
<div class="lb-trans"><p>Cannabix 与 AlcoPro 一直密切合作，主要在美国市场进行 MBT 的预发布营销活动。</p>
</div><p>The Marijuana Breath Test (MBT) system brings together Cannabix’s proprietary Breath Collection Unit and Breath Cartridge technologies to capture and preserve non-invasive breath samples for gold-standard LC-MS analysis. Cannabix’s strategic partnership with Omega Laboratories Inc.—a global leader in forensic drug testing for more than 25 years—adds world-class expertise, backed by multiple federal and international certifications and decades of innovation in drug detection.</p>
<div class="lb-trans"><p>大麻呼气测试（MBT）系统结合了 Cannabix 的专有呼气采集单元和呼气卡匣技术，以捕获和保存非侵入性的呼气样本，供黄金标准的 LC-MS 分析。Cannabix 与 Omega Laboratories Inc.的战略合作伙伴关系——一家在法医药物检测领域拥有超过 25 年经验的全球领导者——为其提供了世界级的专业知识，得到了多个联邦和国际认证的支持，并在药物检测方面拥有数十年的创新经验。</p>
</div><p>Brian Terry, Director of Business Development of AlcoPro stated, “We are exciting about our growing relationship with Cannabix Technologies, and the upcoming availability of the MBT to our clients. We’re moving beyond traditional testing tools and leaning into advanced technologies that deliver the accuracy today’s workplaces demand. As safety challenges shift, staying ahead with solutions that proactively reduce risk is essential to protecting employees.”</p>
<div class="lb-trans"><p>AlcoPro 的业务发展总监 Brian Terry 表示：“我们对与 Cannabix Technologies 日益增长的关系以及 MBT 即将向我们的客户提供感到兴奋。我们正在超越传统的测试工具，转向能够提供当今工作场所所需准确性的先进技术。随着安全挑战的变化，保持领先地位，提供能够主动降低风险的解决方案对于保护员工至关重要。”</p>
</div><p><strong>About AlcoPro, Inc.</strong> Since 1982, AlcoPro has been a trusted leader in drug and alcohol testing solutions for employers, healthcare professionals, law enforcement, and substance abuse specialists. Known for reliable instruments like market-leading breathalyzers, AlcoPro also offers innovative online training with interactive tools to enhance knowledge retention. With a comprehensive product catalog, easy online ordering, and expert support, AlcoPro makes workplace testing simple, accurate, and professional. Learn more at www.AlcoPro.com.</p>
<div class="lb-trans"><p><strong>关于 AlcoPro, Inc.</strong> 自 1982 年以来，AlcoPro 一直是雇主、医疗专业人员、执法机构和药物滥用专家信赖的药物和酒精检测解决方案的领导者。AlcoPro 以市场领先的呼气测酒仪等可靠仪器而闻名，还提供创新的在线培训，配备互动工具以增强知识保留。凭借全面的产品目录、便捷的在线订购和专业支持，AlcoPro 使工作场所检测变得简单、准确和专业。了解更多信息，请访问 www.AlcoPro.com。</p>
</div><p><strong>About Cannabix Technologies Inc.</strong> Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is developing delta-9 THC and alcohol screening devices. Delta-9 THC is the primary psychoactive ingredient in cannabis. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. Cannabix is the developer of its <em>Breath Logix Series of breath alcohol detection devices</em> for employers and a range of other settings.</p>
<div class="lb-trans"><p><strong>关于 Cannabix Technologies Inc.</strong> Cannabix Technologies Inc.是一家为执法机构、工作场所和实验室开发大麻和酒精呼气检测技术的公司。Cannabix 正在开发 delta-9 THC 和酒精筛查设备。Delta-9 THC 是大麻中的主要精神活性成分。对 delta-9 THC 进行呼气检测将使雇主和执法机构能够识别近期的大麻使用。Cannabix 是其_呼气 Logix 系列呼气酒精检测设备_的开发者，适用于雇主和其他多种场合。</p>
</div><p>We seek Safe Harbor.</p>
<div class="lb-trans"><p>我们寻求安全港。</p>
</div><p><em>On behalf of the Board of Directors</em></p>
<div class="lb-trans"><p><em>代表董事会</em></p>
</div><p>“Rav Mlait”</p>
<div class="lb-trans"><p>“Rav Mlait”</p>
</div><p>CEO</p>
<div class="lb-trans"><p>首席执行官</p>
</div><p>Cannabix Technologies Inc.</p>
<div class="lb-trans"><p>Cannabix Technologies Inc.</p>
</div><p>For further information, contact the Company at <strong>info@cannabixtechnologies.com</strong></p>
<div class="lb-trans"><p>如需更多信息，请联系公司，邮箱为 <strong>info@cannabixtechnologies.com</strong></p>
</div><p><strong><em>Cautionary Statement Regarding Forward-Looking Statements</em></strong></p>
<div class="lb-trans"><p><strong><em>关于前瞻性声明的警示说明</em></strong></p>
</div><p><em>This news release contains certain &#34;forward-looking statements&#34; within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as &#34;anticipates,&#34; &#34;plan,&#34; &#34;continue,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;intend,&#34; &#34;believe,&#34; &#34;anticipate,&#34; &#34;estimate,&#34; &#34;may,&#34; &#34;will,&#34; &#34;potential,&#34; &#34;proposed,&#34; &#34;positioned&#34; and other similar words, or statements that certain events or conditions &#34;may&#34; or &#34;will&#34; occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: the achievement of any or all of the goals and aims as described in this news release; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with existing and new partners; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that partners may not complete all or any of the milestones as contemplated strategic partnership agreements; that the CSE may not approve the issuance of the securities; that the Company’s development of breathalyzer technology will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.</em></p>
<div class="lb-trans"><p>本新闻稿包含某些符合适用证券法下 “前瞻性声明” 定义的内容。前瞻性声明通常以 “预期”、“计划”、“继续”、“期望”、“项目”、“打算”、“相信”、“估计”、“可能”、“将”、“潜在”、“提议”、“定位” 等词语或某些事件或条件 “可能” 或 “将” 发生的声明为特征。本新闻稿中的前瞻性声明包括但不限于与以下内容相关的声明：实现本新闻稿中描述的任何或所有目标和目的；商业或原型产品的最终开发；公司技术的成功试验或试点；公司产品的商业化；与现有和新合作伙伴的额外协议的谈判和潜在签署；以及未来融资的完成。有许多风险和不确定性可能导致实际结果以及公司的计划和目标与前瞻性信息中表达的内容存在重大差异。可能导致实际结果与前瞻性信息中表达的内容存在重大差异的重要因素包括（但不限于）：不利的市场条件；关于保护专有技术的风险；公司完成未来融资的能力；公司开发和营销未来产品的能力；关于政府监管、管理和维持增长的风险、不利宣传的影响、诉讼、竞争；合作伙伴可能无法完成所有或任何战略合作协议中设想的里程碑；CSE 可能不批准证券的发行；公司开发的呼气分析仪技术是否会为公司带来任何好处没有保证；没有保证任何提议的新产品会被建造、在测试或临床试验中成功；没有保证公司会与任何合作伙伴建立合作关系以推进其任何企业计划或技术；没有保证公司许可或拥有的任何 “专利申请” 或 “临时专利” 技术会获得监管机构的专利状态；公司目前并未销售呼气分析仪，也没有保证公司将来会销售；以及其他超出公司控制的因素。实际结果和未来事件可能与预期的信息存在重大差异。这些及所有后续的书面和口头前瞻性信息均基于管理层在作出声明时的估计和意见，并完全受到本通知的明确限定。除法律要求外，公司不打算更新这些前瞻性声明。</p>
</div><p><em>The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.</em></p>
<div class="lb-trans"><p>CSE 未对本发布的充分性或准确性进行审查，也不承担任何责任。</p>
</div><p>A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398</p>
<div class="lb-trans"><p>与本公告相关的照片可在 https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398 获取。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYzMDI3MSM3Mzc0NTk3IzIwODcxMjM="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png"/></p>

Cannabix 大麻呼吸测试仪被选为 AlcoPro 2026 年产品目录的封面产品 | BLOZF 股票新闻